Ixico PLC - London-based neuroscience data analytics company - Says that trading in the second half of its financial year ending September 30 is ‘strong’ and expects earnings before interest, tax, depreciation, and amortisation to ‘comfortably’ exceed its previous guidance of £1.2 million. Does not give numbers for expected Ebitda. It was £1.7 million in financial year 2021. Adds that full-year revenue will be in line with market expectations.

Further, guides to £7 million in revenue for financial year 2023, adding that £5 million has already been contracted. That is lower than financial year 2021 revenue of £9.2 million and financial year 2020 revenue of £9.5 million.

Cites diversified order book, with its largest client representing under 15% of projected 2023 revenues. Expects order book at over £15 million at year end, up from £12.6 million at March 31 but down from £18.8 million at September 30, 2021.

Current stock price: 39.41 pence, up 11% on Thursday

12-month change: down 47%

Copyright 2022 Alliance News Limited. All Rights Reserved.